Rhythm Pharmaceuticals, Inc. (RYTM)

NASDAQ: RYTM · Real-Time Price · USD

81.36

-0.76 (-0.93%)

At close: Apr 30, 2026, 4:00 PM EDT

81.25

-0.11 (-0.14%)

After-hours: Apr 30, 2026, 4:37 PM EDT

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Product Revenue, Net	194.77M	130.13M
Product Revenue, Net Growth	49.68%	68.06%
License Revenue	-5.01M	-
Revenue (Other)	-	-
Revenue (Total)	189.76M	130.13M
Revenue (Total) Growth	45.83%	68.06%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
License Revenue	-5.01M	-
United States Revenue	133.55M	96.11M
United States Revenue Growth	38.96%	53.96%
International Revenue	-	34.02M
International Revenue Growth	-	126.74%
Revenue (Other)	61.22M	-
Revenue (Total)	189.76M	130.13M
Revenue (Total) Growth	45.83%	68.06%

Updated Feb 26, 2026. Data Source: Fiscal.ai.